Venetoclax and rituximab: changing the treatment landscape in R/R CLL

Barbara Eichhorst, MD, from Uniklink Koln, Koln, Germany, talks to us about exciting new data for the venetoclax and rituximab combination in the MURANO Phase III trial (NCT02005471) for relapsed/refr... Author: VJHemOnc Added: 07/23/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts